Vesna Jaćević

13PUBLICATIONS
23CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cardiology (incl. cardiovascular diseases)Innate immunityRespiratory diseasesBiologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jul 28, 2026
Amifostine Attenuates Doxorubicin-Induced Subacute Hepatic and Renal Toxicity in Rats.

|Dec 23, 2023
Natural Substances vs. Approved Drugs in the Treatment of Main Cardiovascular Disorders-Is There a Breakthrough?

Jelica Grujić-Milanović, Jovana Rajković, Sladjan Milanović

|Aug 26, 2023
Overexpression of MRP1/ABCC1, Survivin and BCRP/ABCC2 Predicts the Resistance of Diffuse Large B-Cell Lymphoma to R-CHOP Treatment.

Danijela Mandić, Lana Nežić, Ljiljana Amdžić

|Mar 10, 2022
Amelioration of Endotoxin-Induced Acute Lung Injury and Alveolar Epithelial Cells Apoptosis by Simvastatin Is Associated with Up-Regulation of Survivin/NF-kB/p65 Pathway.

Lana Nežić, Ljiljana Amidžić, Ranko Škrbić

|Jun 02, 2021
Resveratrol Protects Cardiac Tissue in Experimental Malignant Hypertension Due to Antioxidant, Anti-Inflammatory, and Anti-Apoptotic Properties.

Jelica Grujić-Milanović, Vesna Jaćević, Zoran Miloradović

|Oct 08, 2020
Antidotal Potency of the Novel, Structurally Different Adsorbents in Rats Acutely Intoxicated with the T-2 Toxin.

Vesna Jaćević, Jelena Dumanović, Miodrag Lazarević

Pageof 3

Frequent Collaborators

6 joint publications

Kamil Kuča

4 joint publications

Jelica Grujić-Milanović

4 joint publications

Lana Nežić

3 joint publications

Sladjan Milanović